Cha Biotech Decides on 250 Billion KRW Rights Offering to Shareholders

KOSDAQ-listed company Cha Biotech announced on the 20th that it has decided to conduct a rights offering followed by a general public offering of forfeited shares to raise approximately 250 billion KRW for operating funds and other purposes.

The issue price is 10,800 KRW per share, and 23,148,150 common shares will be issued.